First published

The bigger mattress business. The cash test.

Explore this signal

Long Term at a glance

Short reader summary

Bigger sales after an acquisition do not automatically make shareholders richer. Somnigroup now owns bedding-component supplier Leggett & Platt. The test is whether integration creates repeat savings and cash per share, rather than simply a bigger business.

Exact asset or item

Somnigroup International Inc. common shares

Asset type

Listed investment

Reference price

59.85 USD per share

Currency code

USD

Price observed at

2026-11-16T16:00:00-05:00

What this number represents

Tracking price

What remains unproven

Historical secondary closing-price reference, not an executable entry or purchase. Entry price unavailable. Research watch, not a buy call. Savings, repeat shareholder cash and investment returns remain unproved.

Exact asset or item

Exact asset or item

Somnigroup International Inc. common shares

Asset type

Listed investment

Ticker

SGI

Exchange

NYSE

How to identify this exact asset

Somnigroup International Inc. common shares, NYSE: SGI. United States; priced in US dollars. This is a two-year research watch, not a buy recommendation or an observed investment.

Price and what it means

Entry or reference price

59.85 USD per share

Currency code

USD

Price observed at

2026-11-16T16:00:00-05:00

What this number represents

Tracking price

Price evidence status

Indicative

Price source

SGI historical regular-session close, 16 November 2026

Original title: SGI Historical Data

Publisher: Yahoo Finance

Original language: English

Reading access: partial

Underlying origin: SGI-PRICE

published date precision: day

retrieved date precision: day

Source publication date 2026-11-16

Source retrieval date 2026-11-17

Matching price source ID

SGI-PRICE

Purchase, sale and realised profit

Historical secondary market record: US$59.85 for the 16 November 2026 regular-session close at 16:00 US Eastern. It is not an executable bid or an OTR purchase. A later review found a conflicting historical-price index and inconsistent cached quote pages, so the reference is not independently settled as a valuation input. Current executable entry price: UNAVAILABLE. No purchase, sale, dividend receipt or investment return is recorded.

The developments we connected

Separate development

  1. What changed

    13 April 2026: all-share agreement

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    The proposed exchange was 0.1455 SGI shares per Leggett share; expected former-holder ownership about 9%. Agreement was a plan, not closing. Date precision is day only.

    Source IDs

    • SGI-AGREEMENT
  2. What changed

    26 August 2026: ownership change completed

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Issuer reported completion; US$75 million annual savings remained a target. Exact event clock unavailable.

    Source IDs

    • SGI-CLOSE
  3. What changed

    9 November 2026: larger reported business, mixed earnings

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Q3 numbers include only the acquired ownership-period contribution; reported profit and adjusted earnings moved in opposite directions. Historical disclosure, not a new 17 November event.

    Source IDs

    • SGI-Q3
    • SGI-10Q

Emerging insight

Somnigroup makes and sells mattresses, and now owns more of the parts business inside them. On 13 April 2026 it proposed an all-share acquisition of Leggett & Platt. On 26 August it reported completing the combination, with former Leggett holders owning about 9% of the combined business. Its 9 November quarterly report then showed the first partial period under the new ownership. The opportunity is not simply a bigger sales number: it is whether bringing supply and production together can leave more repeat cash for each share.

Owning the supplier may remove duplicate costs, improve supply and preserve sales of components to other customers. But factories, employees, borrowing and integration all cost money. Q3 reported sales increased while reported net profit and earnings per share fell. Adjusted earnings improved, so neither headline alone tells the whole story. The next evidence must separate achieved savings from forecasts and show what remains after investment and financing.

There is already a useful comparison within the company. The 2025 Mattress Firm transaction made annual sales much larger, while reported full-year net income stayed near US$384 million, little changed from 2024. That is an observed warning about acquisition-led growth, not proof that the Leggett deal will fail. The narrower long-term question is whether completed integration can turn a larger business into sustained earnings and cash per share.

The signed April deal, August ownership change and November results are different stages. Control of bedding components may improve delivery and remove duplicate spending, but the acquisition itself adds revenue before it proves a return. A larger business can still deliver less profit to each share. Compare the older business, acquired contribution and post-investment cash separately rather than treating the 10.8% sales rise as a mattress-demand boom.

How this exact asset could benefit

The issuer targets US$75 million of annual run-rate Leggett integration savings, increased from the earlier US$50 million target. That is a future annual target, not savings already achieved or a cash receipt. It is separate from the US$75 million of one-time Mattress Firm store-refresh capital spending within roughly US$255 million of expected 2026 capital expenditure. One is a hoped-for benefit; the other is spending.

Shareholders could benefit if repeat earnings and cash per share rise after interest, factory upkeep and integration costs, without expensive new debt or dilution. Savings must survive customer discounts, wages and weaker bedding demand. Around US$5 billion of net indebtedness creates a financing test. The cited 2.69x lender-adjusted debt/earnings ratio uses a denominator that includes US$145 million of future cost savings and US$330.5 million of pre-acquisition earnings. It is not simply debt divided by cash already earned by the consolidated business.

The share price paid and eventual exit price still determine the investment outcome. Better operations do not guarantee a higher share price or an attractive after-cost return.

Who could benefit

  1. Who

    SGI common shareholders, conditionally

    How they could benefit

    Owners of SGI shares could benefit if repeat cash and earnings per share rise without expensive new debt or share dilution. They could lose money if bedding demand slows, the savings arrive late, or too much optimism is already reflected in the share price. The actual share return will also depend on the price paid and eventual sale price.

    Evidence status

    Still unproven

What we observed

Q3 2026 sales were US$2,350.8 million versus US$2,122.6 million, up 10.8%. Reported net profit fell to US$163.5 million from US$177.4 million. Reported diluted earnings per share fell to US$0.74 from US$0.83, while adjusted diluted earnings per share rose to US$1.04 from US$0.95. Gross margin fell to 42.0% from 44.9%. Acquisition-related charges help explain why reported and adjusted results differ; exclusions do not make recurring spending disappear.

A larger business, mixed earningsQ3 2025 → Q3 2026
View comparison values
A larger business, mixed earnings
MeasureBeforeAfter
Sales, US$ million2,122.62,350.8
Reported net income, US$ million177.4163.5
Reported EPS, US$ per share0.830.74
Adjusted EPS, US$ per share0.951.04
Each row has its own stated unit, not a shared numeric axis. 2026 includes the acquired Leggett ownership period only; adjusted and reported earnings differ.
Sources
  • Somnigroup Q3 results · 9 November 2026

Leggett contributed US$372.6 million of sales and US$10 million of net income only for 26 August–30 September. Subtracting acquired sales leaves US$1,978.2 million, 6.8% below the prior-year total. This is arithmetic, not a formally reported organic or constant-currency growth measure: the partial acquired period and business mix must remain visible.

Nine-month operating cash was US$831.9 million versus US$700.7 million. Subtracting property, plant and equipment purchases of US$174.3 million and US$108.6 million respectively leaves US$657.6 million versus US$592.1 million, a US$65.5 million increase, about 11.1%. This derived cash-after-capital-spending proxy is not company-defined free cash flow, normalised earnings or cash distributable to shareholders. It is not evidence that cash per share has already been declining.

What remains after capital spendingNine months ended 30 September 2026 · US$ million
Value
Vertical scale 0 to 900Ticks 0 · 300 · 600 · 900
View chart values
What remains after capital spending
StepKindValue
Operating cashstart831.9
Capital spendingchange-174.3
Cash after capextotal657.6
Calculated 831.9 − 174.3 = 657.6. Not company-defined free cash, shareholder distributable cash or merger-caused gain. Prior-year equivalent 592.1; do not annualise.
Sources
  • Somnigroup SEC Q3 10-Q cash-flow statement · November 2026

Dated enrichment, 17 November: Mattress Firm and Tempur Sealy North America sales each fell 5.8%; International fell 12.3%, including disruption from a new Dreams business system. North American margin improvement included tariff refunds and earlier Mattress Firm savings, not proof the new Leggett target was achieved. Subtracting the acquisition's sales from the total is not a formal organic-growth calculation.

What remains unproven

Unknowns include achieved savings, sustained demand, normalised cash per share, financing costs, future dilution and a reliable executable entry price. Positive adjusted earnings do not settle these questions.

What to check before acting

Entry conditions

Check whether the company actually reports cost savings rather than only describing them. Then compare debt, interest payments and the number of shares with the extra profits. If profit rises only because numbers are adjusted to exclude one-off charges, ask whether such charges keep returning.

Possible upside

Upside: achieved savings and stronger repeat cash survive weak consumer demand, and more value reaches each share. Middle: sales rise but the benefit to shareholders remains modest. Downside: high debt, lower margins and slow mattress demand erase the expected benefit. No numerical price scenarios, probabilities or guaranteed returns are estimated.

Possible downside

Counter-evidence is already visible: lower reported quarterly net profit and gross margin despite higher sales, a substantial debt burden and savings still described as a target. The earlier Mattress Firm sales/profit contrast is a useful historical challenge. Company releases and SEC filings share one issuer origin; they are not independent customer confirmation. No separate independent commercial evidence of realised integration savings was established.

Price or return range method

The US$59.85 historical reference is not a live offer. A first forward entry observation would require a source-timed broker quote after this issue, with bid, ask and applicable costs. Historical-price disagreement remains unresolved, and a current valuation cannot be established here. If a sensitivity table uses that old reference and management guidance, it must label both assumptions and must not present the result as current fair value or a buy threshold.

Dated enrichment, 17 November 2026: divide the historical US$59.85 reference by management's 9 November FY2026 adjusted-EPS guidance of US$2.85–2.95. The resulting 20.3–21.0 times is an arithmetic sensitivity, not a fair-value range, GAAP multiple, executable entry or return forecast. At US$2.90 the multiple is 20.64. Management could not reconcile this forward adjusted guidance to GAAP without unreasonable effort. A defensible share-price target still lacks a justified future multiple, normalised post-integration earnings, repeat cash, and sufficiently supported long-run growth and capital assumptions. Those missing inputs are not filled with invented estimates.

One historical price, three earnings assumptionsGuidance dated 9 November; historical close 16 November 2026
One historical price, three earnings assumptions
Management FY2026 adjusted EPS (USD)Historical reference (USD)Calculated price / adjusted EPS
2.85 — low guidance59.8521.00×
2.90 — guidance midpoint59.8520.64×
2.95 — high guidance59.8520.29×
Arithmetic sensitivity only, not fair value, executable entry, GAAP multiple or return forecast. Historical quote discrepancy unresolved; guidance can fail and is not reconciled to forward GAAP EPS.
Sources
  • Somnigroup Q3 guidance; historical secondary price records · 9 and 16 November 2026

Costs and fees

A reader considering a US-listed share must check broker eligibility, live bid/ask spread, dealing fees, foreign-exchange charges, withholding and tax treatment, and the ability to sell. SGD/USD movements can change a Singapore investor's return. No account-specific fee schedule or current broker access was verified.

Risks include weak mattress demand, store competition, changing import tariffs, factory costs, integration delays, legal costs and further acquisitions. Around US$5 billion of net indebtedness means interest and refinancing matter. Recurring adjustment charges may make adjusted earnings look better than cash economics. Losses could include the full investment.

Illustration only: ten shares bought at a fictional US$60 and sold at a fictional US$70 produce US$100 before costs. Deduct fictional US$20 trading and currency charges to leave US$80 before tax. These are teaching assumptions, not SGI transaction prices, an actual return or a forecast.

How hard it may be to sell

NYSE listing does not guarantee a suitable price whenever a holder wants to sell. Spreads, market conditions and currency conversion affect proceeds. Check market hours and the actual broker quote; no trade is instructed.

Key risks

Reported and adjusted results are both relevant; the sources have one issuer lineage. Integration, tariffs, borrowing and weaker bedding demand can prevent the proposed cash benefit. Shareholder outcome also depends on entry and sale prices.

What an ordinary reader can do next

Start with a free research notebook, not a purchase. Keep three rows: the older business, the acquired business and cash left after necessary spending. Compare with the same quarter last year and preserve the acquisition's partial reporting period. Check whether the company reports achieved savings rather than repeating targets.

Then compare interest, debt and share count with extra profit. If improvement depends on adjustments, ask whether the supposedly one-off charges recur. The first scheduled review is 17 May 2027, using Q4 2026 and Q1 2027. Do not spend on the assumption that the historical quote is available now. This report is not an order instruction.

Original forecast record

Original forecast in full

Somnigroup may turn its completed Leggett & Platt supplier acquisition into repeat savings and stronger shareholder cash over two years, but Q3 2026 sales growth from the acquired business arrived alongside falling reported net profit and a large debt burden.

UNRESOLVED / NOT YET DUE. No OTR purchase, sale, realised return or completed future checkpoint. Keep original dated claims and losing calls; append later evidence rather than rewriting the forecast. The historical Mattress Firm comparison is not an OTR forecasting success record.

17 November 2026. Original research cutoff: 14:20 SGT. The source records a retrieval batch from approximately 14:13 to 14:22 SGT; checks after 14:20 are later verification, not information secretly moved inside the cutoff. Exact per-page access seconds were not retained. Subsequent review clarifications on 17 November are labelled below; this is historical long-term research, not a claim of a new event within the last 24 hours.

Use dated filings to test acquired versus older-business sales, reported and adjusted profit, shares outstanding, achieved savings, interest and debt, and cash after capital expenditure. Keep acquisition periods and changing business mix explicit. At the five-year review compare the full record, including negative results and any documented after-cost shareholder outcome. No purchase means no realised investment return can be attributed to this watch.

Frozen original failure rule: if by 2028-11-17 repeated filings show weak post-investment cash, lower profit per share and no verifiable integration savings while debt stays high, mark the original value mechanism contradicted or partly following, not a hit.

Dated clarification, 17 November 2026: the original six-month wording 'cash per share keep declining' is a future weakening condition, not an established baseline. The available cash-after-capital-spending proxy rose in the nine-month comparison; no verified cash-per-share declining series was established. The original combined failure rule requires its conditions to be assessed together. Mixed evidence is not automatically a complete failure or a hit; missing comparable data is unassessable. This clarification does not rewrite the frozen claim or six dates.

Seven Astra reviewers read the full 19-page source and ten-page presentation reference and discussed the revision: counter-evidence, economics, editorial integrity, independent investment review, independent long-term review and two ordinary-reader reviews. The publisher's synthesis preserves source qualifications; model agreement is not external evidence. The later independent source-check window was approximately 16:08–16:11 SGT on 17 November, with review completion recorded at 16:10:55 SGT, not an exact per-source HTTP time. Source-backed enrichment distinguishes GAAP and adjusted results, acquired stub-period sales, debt-ratio adjustments, spending versus savings, and the unresolved quote discrepancy.

Editorial classification clarification, 17 November 2026: if all combined failure conditions are met, the value mechanism is contradicted. Partly following requires genuine mixed confirming evidence, not failure alone.

Original forecast date and time

2026-11-17T14:20:00+08:00

Forecasts and review dates

6 months

Review date

2027-05-17

Original forecast

Read Q4 2026 and Q1 2027 earnings. Separate acquired sales from organic sales; compare reported margin and cash.

What to measure

Quarterly acquired and existing-business sales, margins, shares and cash.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

Revenue rises because of acquisition while net profit and cash per share keep declining.

Current outcome

Not yet due

1 year

Review date

2027-11-17

Original forecast

Look for documented achieved integration savings, lower cost per unit, and audited debt ratios.

What to measure

Achieved savings, cost per unit and debt definition.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

Only future savings targets are repeated, without measurable delivery or financing benefit.

Current outcome

Not yet due

2 years

Review date

2028-11-17

Original forecast

Assess two full post-merger years of free cash flow, earnings per share and debt after factory investment.

What to measure

Two-year cash after investment, per-share earnings and indebtedness.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

Free cash is persistently weak or debt and new shares absorb most apparent savings.

Current outcome

Not yet due

3 years

Review date

2029-11-17

Original forecast

Measure operating profit and cash through different bedding demand conditions, adjusting for new purchases.

What to measure

Cycle-adjusted operating earnings, capital needs and interest.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

Sales are higher but long-run capital needs and interest keep cash returns low.

Current outcome

Not yet due

4 years

Review date

2030-11-17

Original forecast

Verify whether supplier ownership gives repeat service, pricing power or measurable lower costs.

What to measure

Repeat customer economics, pricing and cost evidence.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

Rivals or consumers resist prices, or vertical integration erodes competition and margins.

Current outcome

Not yet due

5 years

Review date

2031-11-17

Original forecast

Compare five annual records with the frozen 2026 claim: profit per share, debt, share count, free cash and share-market outcome after costs.

What to measure

Five-year operating record and any separately documented after-cost share return.

What must happen

Later dated filings must establish the proposed benefit for this horizon; projections and a higher share price alone do not satisfy the operating test.

What would challenge the forecast

The value pathway never emerges, or share returns remain negative even if operations improved.

Current outcome

Not yet due

Sources

Dated source

  1. Source ID

    SGI-Q3

    What this source supports

    Sales, reported versus adjusted earnings, debt, forward guidance and segment counterevidence. Original issuer disclosure; not independent proof of future savings. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  2. Source ID

    SGI-10Q

    What this source supports

    Cash flow, acquisition accounting and lender-defined leverage. Relevant tables checked; not every filing passage independently audited. SEC filing index independently checked 17 November: filed 9 November 2026, accepted 16:12:50 EDGAR clock. This establishes the filing day independently of the earnings release. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  3. Source ID

    SGI-CLOSE

    What this source supports

    Completed transaction and annual savings target; issuer perspective. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  4. Source ID

    SGI-AGREEMENT

    What this source supports

    Historical exchange ratio and expected ownership; source author opened, not newly re-audited here. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  5. Source ID

    SGI-FY25

    What this source supports

    Mattress Firm historical sales/profit comparison, not a forecast law; issuer source read by supplied research and independent reviewer. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  6. Source ID

    SGI-Q2

    What this source supports

    Earlier financial comparison; original source author's direct read, not a fresh full audit. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  7. Source ID

    SGI-PRICE

    What this source supports

    Historical US$59.85 regular close at 16:00 EST. Indexed table; direct page 429. Secondary records conflict; not live/executable. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

  8. Source ID

    SGI-QUOTE-CHECK

    What this source supports

    Reviewer directly corroborated dated US$59.85 close; secondary, not exchange execution. Quote can subsequently change. Original source review window approximately 14:13–14:22 SGT on 17 November; later publisher/reviewer checks separately dated 17 November, exact per-URL seconds unavailable.

Source limits

Original source cutoff: 17 November 2026, 14:20 SGT. Original checks ran approximately 14:13–14:22 SGT, so verification continued two minutes beyond that cutoff; exact per-link seconds are unavailable. Further focused verification on 17 November is separately dated, not a newly occurring merger or earnings event. This is a historical-evidence Long Term watch, not a fresh 24-hour news claim. Review-record correction, 17 November 2026: six Astra-configured reviewers completed the full 19-page source and 10-page presentation-reference reads before publication. A seventh contributed a partial source review and a full reference read, but did not complete the full source. The earlier statement of seven complete reads was inaccurate. Later verification cannot retroactively satisfy that prepublication requirement. Source methods and access limits are stated with the final register; no exhaustive independent audit, trade or future outcome is claimed.

Signal history

Published changes
  • Updated the evidence and sources.

Back to Signals

AI powered research